ArticleAmerican journal of cancer research2015

Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.

Qiang Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.